JP2005052149A5 - - Google Patents

Download PDF

Info

Publication number
JP2005052149A5
JP2005052149A5 JP2004293969A JP2004293969A JP2005052149A5 JP 2005052149 A5 JP2005052149 A5 JP 2005052149A5 JP 2004293969 A JP2004293969 A JP 2004293969A JP 2004293969 A JP2004293969 A JP 2004293969A JP 2005052149 A5 JP2005052149 A5 JP 2005052149A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004293969A
Other languages
Japanese (ja)
Other versions
JP2005052149A (ja
Filing date
Publication date
Priority claimed from GBGB9815879.3A external-priority patent/GB9815879D0/en
Priority claimed from GBGB9906712.6A external-priority patent/GB9906712D0/en
Priority claimed from GBGB9909494.8A external-priority patent/GB9909494D0/en
Application filed filed Critical
Publication of JP2005052149A publication Critical patent/JP2005052149A/ja
Publication of JP2005052149A5 publication Critical patent/JP2005052149A5/ja
Pending legal-status Critical Current

Links

JP2004293969A 1998-07-21 2004-10-06 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド Pending JP2005052149A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9815879.3A GB9815879D0 (en) 1998-07-21 1998-07-21 A polynucleotide
US10768898P 1998-11-09 1998-11-09
GBGB9906712.6A GB9906712D0 (en) 1999-03-23 1999-03-23 A polynucleotide
US12741099P 1999-04-01 1999-04-01
GBGB9909494.8A GB9909494D0 (en) 1999-04-23 1999-04-23 A plasmid
US13401699P 1999-05-12 1999-05-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000561339A Division JP4220673B2 (ja) 1998-07-21 1999-07-21 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007285560A Division JP2008109931A (ja) 1998-07-21 2007-11-01 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド

Publications (2)

Publication Number Publication Date
JP2005052149A JP2005052149A (ja) 2005-03-03
JP2005052149A5 true JP2005052149A5 (enExample) 2005-09-29

Family

ID=27547316

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2000561339A Expired - Lifetime JP4220673B2 (ja) 1998-07-21 1999-07-21 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド
JP2004293969A Pending JP2005052149A (ja) 1998-07-21 2004-10-06 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド
JP2007285560A Withdrawn JP2008109931A (ja) 1998-07-21 2007-11-01 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド
JP2008305611A Withdrawn JP2009102331A (ja) 1998-07-21 2008-11-28 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000561339A Expired - Lifetime JP4220673B2 (ja) 1998-07-21 1999-07-21 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007285560A Withdrawn JP2008109931A (ja) 1998-07-21 2007-11-01 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド
JP2008305611A Withdrawn JP2009102331A (ja) 1998-07-21 2008-11-28 遍在性クロマチンオープニングエレメント(ucoe)を含むポリヌクレオチド

Country Status (8)

Country Link
EP (2) EP2348118A1 (enExample)
JP (4) JP4220673B2 (enExample)
KR (3) KR100795626B1 (enExample)
CN (1) CN100365127C (enExample)
AU (1) AU771111B2 (enExample)
CA (1) CA2333852C (enExample)
MX (1) MXPA01000830A (enExample)
WO (1) WO2000005393A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9006701A (en) 2000-09-20 2002-04-02 Cobra Therapeutics Ltd Polynucleotide
ES2330201T3 (es) 2001-01-26 2009-12-07 Selexis S.A. Regiones de union a la matriz y metodos para el uso de las mismas.
AU2002242872B2 (en) 2001-04-05 2006-12-14 Emd Millipore Corporation Improved gene expression
US7812148B2 (en) 2001-04-05 2010-10-12 Millipore Corporation Vectors comprising CpG islands without position effect varigation and having increased expression
KR100955756B1 (ko) * 2001-04-05 2010-04-30 밀리포어 코포레이션 개량된 유전자 발현
BR0209989A (pt) 2001-05-30 2005-04-12 Chromos Molecular Systems Inc Plataformas baseadas em cromossomas
US20040161817A1 (en) * 2001-06-04 2004-08-19 Corixa Corporation Compositions and methods for high-level, large-scale production of recombinant proteins
ES2344070T3 (es) 2001-07-04 2010-08-17 Chromagenics B.V. Secuencias de adn con actividad anti-represora.
EP1465993B1 (en) 2002-01-09 2009-09-23 Minos Biosystems Limited Inducible transposition in transgenic organism using transposon vector
NZ537073A (en) 2002-06-14 2006-08-31 Chromagenics B A method for simultaneous production of multiple proteins; vectors and cells for use therein
AU2003243059A1 (en) 2002-06-14 2003-12-31 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
ES2373549T3 (es) 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
AU2003290453A1 (en) 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
ES2345335T3 (es) 2003-02-01 2010-09-21 Millipore Corporation Elementos geneticos mejorados que proporcionan altos niveles de expresion.
EP1959011B1 (en) 2003-10-24 2012-03-28 Selexis S.A. High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
ATE546531T1 (de) * 2003-12-31 2012-03-15 Kalobios Inc Transaktivierungssystem für säugerzellen
KR20070038556A (ko) 2004-07-20 2007-04-10 심포젠 에이/에스 항-rhesus d 재조합 폴리클로날 항체 및 이의 제조방법
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
AU2005300503B2 (en) 2004-11-08 2010-12-16 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060172382A1 (en) 2004-11-08 2006-08-03 Chromagenics B.V. Selection of host cells expressing protein at high levels
GB0504587D0 (en) 2005-03-05 2005-04-13 Ml Lab Plc Vectors comprising guinea pig CMV regulatory elements
GB0509965D0 (en) 2005-05-17 2005-06-22 Ml Lab Plc Improved expression elements
WO2007081336A1 (en) * 2006-01-13 2007-07-19 Five Prime Therapeutics, Inc. Mammalian vectors for high-level expression of recombinant proteins
US7968700B2 (en) 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof
EP2118270A2 (en) * 2007-01-08 2009-11-18 Millipore Corporation Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
CN104531699B (zh) * 2014-10-09 2017-03-15 河南农业大学 一种增强外源基因表达的猪的ucoe调控元件片段
EP3234128B1 (en) * 2014-12-16 2025-06-18 Garvan Institute of Medical Research Sequencing controls
CN110431227A (zh) * 2017-03-19 2019-11-08 应用干细胞有限公司 新型整合位点及其用途
AU2018249444A1 (en) 2017-04-03 2019-10-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for multiplexed quantitative analysis of cell lineages
EP3720958A1 (en) * 2017-12-07 2020-10-14 Integrity Biosolutions, LLC Engineered ubiquitous chromatin opening elements and uses thereof
CN112135909A (zh) * 2018-05-24 2020-12-25 国立大学法人北海道大学 新载体及其应用
BR112021002779A2 (pt) 2018-08-15 2021-05-04 Illumina, Inc. composições e métodos para melhorar o enriquecimento de bibliotecas
AU2019354390A1 (en) * 2018-10-02 2021-04-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for multiplexed quantitative analysis of cell lineages
US20220193266A1 (en) * 2019-04-30 2022-06-23 Chan Zuckerberg Biohub, Inc. A novel chromatin-opening element for stable long term gene expression
CN112575031B (zh) * 2019-09-29 2023-04-07 新乡医学院 一种遍在染色质开放表达元件、重组表达载体、表达系统及其制备方法、应用
CN116574735B (zh) * 2023-07-03 2023-11-10 艾米能斯(苏州)生物科技有限公司 一种多核苷酸及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
GB8718779D0 (en) 1987-08-07 1987-09-16 Grosveld F G Dna sequence & expression vector
AU635844B2 (en) 1989-11-06 1993-04-01 Cell Genesys, Inc. Production of proteins using homologous recombination
JP3222461B2 (ja) 1990-05-18 2001-10-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規タンパク質―ポリカチオン結合体
AU7906691A (en) 1990-05-23 1991-12-10 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Adeno-associated virus (aav)-based eucaryotic vectors
GB9109928D0 (en) 1991-05-08 1991-07-03 Interox Chemicals Ltd Thickened compositions
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
CA2131620A1 (en) 1992-03-20 1993-09-30 Louis C. Smith A dna transporter system and method of use
US5583009A (en) 1992-12-08 1996-12-10 University Of Washington Method of preparing recombinant proteins in transgenic animals containing metallothionein gene elements that bestow tissue-independent copy number-dependent, position-indepedent gene expression
US5578475A (en) 1993-07-12 1996-11-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
AU6011496A (en) 1995-06-08 1997-01-09 Therexsys Limited Improved pharmaceutical compositions for gene therapy
DE69704206T2 (de) 1996-08-16 2001-08-30 Medical Research Council, London Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln
DE19651443A1 (de) 1996-12-11 1998-06-18 Hoechst Ag Selbstverstärkende, pharmakologisch kontrollierbare Expressionssysteme
EP1007549B1 (en) 1997-02-12 2006-12-27 Innovata Plc Compositions and methods for highly efficient transfection

Similar Documents

Publication Publication Date Title
JP2005046158A5 (enExample)
JP2005123607A5 (enExample)
DE602005018222D1 (enExample)
JP2005252388A5 (enExample)
JP2005052149A5 (enExample)
IN2006DE05581A (enExample)
JP2004358259A5 (enExample)
JP2005312264A5 (enExample)
JP2005329506A5 (enExample)
GB2426048A8 (enExample)
JP2005007166A5 (enExample)
JP2004356097A5 (enExample)
IN2006DE05679A (enExample)
JP2005017273A5 (enExample)
DE602005012956D1 (enExample)
JP2004280083A5 (enExample)
JP2005241603A5 (enExample)
JP2005061418A5 (enExample)
JP2005150104A5 (enExample)
JP2005194264A5 (enExample)
JP2005119272A5 (enExample)
JP2005293328A5 (enExample)
JP2005308026A5 (enExample)
JP2005296475A5 (enExample)
JP2005141723A5 (enExample)